Published in Biotech Business Week, December 20th, 2004
The securities were sold pursuant to Rule 506 of the Securities Act and thus were exempt from the registration requirements of the Securities Act of 1933. The transaction is not open to additional investors.
Punk, Ziegel & Co. and Trout Capital LLC acted as placement agents for the transaction.
VaxGen, Inc. is a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.